Latest filing published 24 Sept 2026 for Mantra Pharma Inc., €6,214. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Rajinder Chowdhry across 4 companies, led by AsiaBaseMetals Inc., Mantra 2 Real Estate Inc. and Mantra Pharma Inc. Over a trading history stretching from 8 February 2026 to 24 September 2026, the count stands at 22 filings.
On the open market, the record shows 10 purchases worth €830 and 1 sale worth €6,191. Taken together, the sales exceed the purchases by €5,361. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 option exercises.
In size, the median ticket on the buying side is €56. Relative to company size, the median is 0.0020% of market cap (9 purchases with a known value). Across 10 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 24 September 2026 with an option exercise (€6,214) in Mantra Pharma Inc. The last insider purchase was made public on 23 September 2026, 24 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations